Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859)

  • Details

ClinicalTrials.gov ID: NCT03675737
Diagnosis Type: NA
USOR Number: 18097

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

BO39633 (IMbrella A), An open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in A Genentech- and/or F.Hoffman-La Roche Ltd. sponsored Atezolizumab Study

  • Details

ClinicalTrials.gov ID: NCT03148418
Diagnosis Type: NSCLC
USOR Number: 17087

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM-202)

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NA
USOR Number: 17140

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NSCLC
USOR Number: 17140

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Minnesota Oncology - Minneapolis

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)

  • Details

ClinicalTrials.gov ID: NCT02954991
Diagnosis Type: NSCLC
USOR Number: 17039

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Pages